2 weeks till new fibro drug?

UPDATE: FDA Panel rejects sodium oxybate by a vote of 20 to 2. This is a recommendation and the final decision will be given in October. Pregablin suffered a similar defeat at this stage but the outlook is not good for this drugs approval despite the positive trials.

Following up on your previous article on sodium oxybate in December last year, the time is fast approaching where we will find out if the New drug application by Jazz pharmaceuticals will be approved by the FDA. 

In June 2009 when we spoke about Sodium Oxybate the following was said about positive trials:

Jazz Pharmaceuticals and UCB announced on 24th June 2009 that there have been positive preliminary  results from the second of two Phase III clinical trials of Sodium Oxybate (JZP-6) for treatment in Fibromyalgia.

Of course when we find out more about this promising addition to the fibro meds on offer we will let you know. You can read Adrienne Dellewo's take on this here.

Last Updated on Thursday, 16 September 2010 09:34 Created: Saturday, 07 August 2010 13:49